AstraZeneca accepted in a legal submission that their Covid vaccine Covishield can cause Thrombosis with Thrombocytopenia Syndrome. | Latest News India
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a side effect in some people.
The UK said the country is “continuing to engage” with India to expand its recognition of Covid-19 vaccine certification, hours after India imposed counter measures on UK nationals traveling to India.
The British government is yet to officially respond to India’s plans to impose quarantine restrictions on vaccinated British travellers from Monday, in a retaliatory move against India not being recognised on a list of 18 vaccine-eligible countries.
The row between India and UK over travel norms stems from the Indian government's efforts to get the UK to recognise Covishield as a legitimate vaccine